Hemotherapy in cardiac surgery

Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00209775%3A_____%2F12%3A%230000233" target="_blank" >RIV/00209775:_____/12:#0000233 - isvavai.cz</a>
Result on the web
<a href="http://intechopen.com/books/perioperative-considerations-in-cardiac-surgery" target="_blank" >http://intechopen.com/books/perioperative-considerations-in-cardiac-surgery</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.5772/1455" target="_blank" >10.5772/1455</a>

Result language
angličtina
Original language name
Hemotherapy in cardiac surgery
Original language description
Demands for allogeneic blood transfusion in cardiac surgery were still high two decades ago. Today there is a gradual decline in transfusion requirements owing to recent advances in cardiac surgery and related specialties that have together developed techniques for peri-operative blood salvage and its autotransfusion: this trend continues to progress towards bloodless surgery. Its milestones have included a refinement of surgical methods, a better understanding of bleeding pathology related to extracorporeal circulation and an introduction of coagulation monitoring during surgery, using point-of-care testing. A significant advancement in extracorporeal circulation came with the development of less aggressive, more biocompatible and miniature-circuit systems. As a result, allogeneic blood transfusion is currently not needed in over 50% of all surgical procedures and in almost 100% of coronary heart operations. However, over 40% of patients undergoing cardiac surgery still require alloge
Czech name
—
Czech description
—

Publication year
2012
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Similar results(10)